ReP USP - Resultado da busca

Artigo de periodico
Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10 (2015)
Melo, Filipe M. de; Braga, Catarina Joelma Magalhães; Pereira, Felipe V.; Maricato, Juliana T.; Origassa, Clarice S. T.; Souza, Mariana F.; Melo, Amanda C.; Silva, Priscila; Tomaz, Samanta L.; Gimenes, Karina Panizzi; Scutti, Jorge A. Borin; Juliano, Maria Aparecida; Zamboni, Dario Simões; Câmara, Niels Olsen Saraiva ; Travassos, Luiz R.; Ferreira, Luís Carlos de Souza ; Rodrigues, Elaine G.
Fonte: Immunology and Cell Biology. Unidades: FMRP, ICB
Assuntos: IMUNOTERAPIA, ADJUVANTES IMUNOLÓGICOS, PARACOCCIDIOIDES BRASILIENSIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Filipe M. de et al. Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10. Immunology and Cell Biology, v. 93, n. 1, p. 86–98, 2015Tradução . . Disponível em: https://doi.org/10.1038/icb.2014.74. Acesso em: 19 maio 2024.
APA
Melo, F. M. de, Braga, C. J. M., Pereira, F. V., Maricato, J. T., Origassa, C. S. T., Souza, M. F., et al. (2015). Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10. Immunology and Cell Biology, 93( 1), 86–98. doi:10.1038/icb.2014.74
NLM
Melo FM de, Braga CJM, Pereira FV, Maricato JT, Origassa CST, Souza MF, Melo AC, Silva P, Tomaz SL, Gimenes KP, Scutti JAB, Juliano MA, Zamboni DS, Câmara NOS, Travassos LR, Ferreira LC de S, Rodrigues EG. Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10 [Internet]. Immunology and Cell Biology. 2015 ; 93( 1): 86–98.[citado 2024 maio 19 ] Available from: https://doi.org/10.1038/icb.2014.74
Vancouver
Melo FM de, Braga CJM, Pereira FV, Maricato JT, Origassa CST, Souza MF, Melo AC, Silva P, Tomaz SL, Gimenes KP, Scutti JAB, Juliano MA, Zamboni DS, Câmara NOS, Travassos LR, Ferreira LC de S, Rodrigues EG. Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10 [Internet]. Immunology and Cell Biology. 2015 ; 93( 1): 86–98.[citado 2024 maio 19 ] Available from: https://doi.org/10.1038/icb.2014.74
Artigo de periodico
Malaria vaccine development: are bacterial flagellin fusion proteins the bridge between mouse and humans? (2011)
Bargieri, Daniel Youssef ; Soares, Irene da Silva ; Costa, Fabio T. M; Braga, Catarina Joelma Magalhães; Ferreira, Luís Carlos de Souza ; Rodrigues, Mauricio Martins
Fonte: Journal of Parasitology Research. Unidades: ICB, FCF
Assuntos: VACINAS (DESENVOLVIMENTO), MALÁRIA, IMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARGIERI, Daniel Youssef et al. Malaria vaccine development: are bacterial flagellin fusion proteins the bridge between mouse and humans?. Journal of Parasitology Research, v. 2011, p. 1-10, 2011Tradução . . Disponível em: https://doi.org/10.1155/2011/965369. Acesso em: 19 maio 2024.
APA
Bargieri, D. Y., Soares, I. da S., Costa, F. T. M., Braga, C. J. M., Ferreira, L. C. de S., & Rodrigues, M. M. (2011). Malaria vaccine development: are bacterial flagellin fusion proteins the bridge between mouse and humans? Journal of Parasitology Research, 2011, 1-10. doi:10.1155/2011/965369
NLM
Bargieri DY, Soares I da S, Costa FTM, Braga CJM, Ferreira LC de S, Rodrigues MM. Malaria vaccine development: are bacterial flagellin fusion proteins the bridge between mouse and humans? [Internet]. Journal of Parasitology Research. 2011 ; 2011 1-10.[citado 2024 maio 19 ] Available from: https://doi.org/10.1155/2011/965369
Vancouver
Bargieri DY, Soares I da S, Costa FTM, Braga CJM, Ferreira LC de S, Rodrigues MM. Malaria vaccine development: are bacterial flagellin fusion proteins the bridge between mouse and humans? [Internet]. Journal of Parasitology Research. 2011 ; 2011 1-10.[citado 2024 maio 19 ] Available from: https://doi.org/10.1155/2011/965369
Artigo de periodico
Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity (2011)
Porchia, Bruna Felicio Milazzotto Maldonado; Diniz, Mariana O.; Cariri, Francisco A. M. O.; Santana, Vinícius C.; Amorim, Jaime H.; Balan, Andrea ; Braga, Catarina Joelma Magalhães; Ferreira, Luís Carlos de Souza
Fonte: Molecular Pharmaceutics. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PORCHIA, Bruna Felicio Milazzotto Maldonado et al. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity. Molecular Pharmaceutics, v. 8, n. 6, p. 2320-2330, 2011Tradução . . Disponível em: https://doi.org/10.1021/mp200194s. Acesso em: 19 maio 2024.
APA
Porchia, B. F. M. M., Diniz, M. O., Cariri, F. A. M. O., Santana, V. C., Amorim, J. H., Balan, A., et al. (2011). Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity. Molecular Pharmaceutics, 8( 6), 2320-2330. doi:10.1021/mp200194s
NLM
Porchia BFMM, Diniz MO, Cariri FAMO, Santana VC, Amorim JH, Balan A, Braga CJM, Ferreira LC de S. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity [Internet]. Molecular Pharmaceutics. 2011 ; 8( 6): 2320-2330.[citado 2024 maio 19 ] Available from: https://doi.org/10.1021/mp200194s
Vancouver
Porchia BFMM, Diniz MO, Cariri FAMO, Santana VC, Amorim JH, Balan A, Braga CJM, Ferreira LC de S. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity [Internet]. Molecular Pharmaceutics. 2011 ; 8( 6): 2320-2330.[citado 2024 maio 19 ] Available from: https://doi.org/10.1021/mp200194s
Artigo de periodico
Production of native flagellin from Salmonella Typhimurium in a bioreactor and purification by tangential ultrafiltration (2011)
Oliveira, B. H.; Silva, M. R.; Braga, Catarina Joelma Magalhães; Massis, Liliana Moura; Ferreira, Luís Carlos de Souza ; Sbrogio-Almeida, M. E.; Takagi, M.
Fonte: Brazilian Journal of Chemical Engineering. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, B. H. et al. Production of native flagellin from Salmonella Typhimurium in a bioreactor and purification by tangential ultrafiltration. Brazilian Journal of Chemical Engineering, v. 28, n. 4, p. 575-584, 2011Tradução . . Disponível em: https://doi.org/10.1590/s0104-66322011000400003. Acesso em: 19 maio 2024.
APA
Oliveira, B. H., Silva, M. R., Braga, C. J. M., Massis, L. M., Ferreira, L. C. de S., Sbrogio-Almeida, M. E., & Takagi, M. (2011). Production of native flagellin from Salmonella Typhimurium in a bioreactor and purification by tangential ultrafiltration. Brazilian Journal of Chemical Engineering, 28( 4), 575-584. doi:10.1590/s0104-66322011000400003
NLM
Oliveira BH, Silva MR, Braga CJM, Massis LM, Ferreira LC de S, Sbrogio-Almeida ME, Takagi M. Production of native flagellin from Salmonella Typhimurium in a bioreactor and purification by tangential ultrafiltration [Internet]. Brazilian Journal of Chemical Engineering. 2011 ; 28( 4): 575-584.[citado 2024 maio 19 ] Available from: https://doi.org/10.1590/s0104-66322011000400003
Vancouver
Oliveira BH, Silva MR, Braga CJM, Massis LM, Ferreira LC de S, Sbrogio-Almeida ME, Takagi M. Production of native flagellin from Salmonella Typhimurium in a bioreactor and purification by tangential ultrafiltration [Internet]. Brazilian Journal of Chemical Engineering. 2011 ; 28( 4): 575-584.[citado 2024 maio 19 ] Available from: https://doi.org/10.1590/s0104-66322011000400003
Artigo de periodico
CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein (2010)
Braga, Catarina Joelma Magalhães; Massis, Liliana Moura; Sbrogio-Almeida, Maria E.; Bargieri, Bruna Cunha de Alencar ; Bargieri, Daniel Youssef ; Boscardin, Silvia Beatriz ; Rodrigues, Maurício M.; Ferreira, Luís Carlos de Souza
Fonte: Vaccine. Unidade: ICB
Assuntos: MICROBIOLOGIA, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Catarina Joelma Magalhães et al. CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein. Vaccine, v. 28, n. 5, p. 1373-1382, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2009.11.003. Acesso em: 19 maio 2024.
APA
Braga, C. J. M., Massis, L. M., Sbrogio-Almeida, M. E., Bargieri, B. C. de A., Bargieri, D. Y., Boscardin, S. B., et al. (2010). CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein. Vaccine, 28( 5), 1373-1382. doi:10.1016/j.vaccine.2009.11.003
NLM
Braga CJM, Massis LM, Sbrogio-Almeida ME, Bargieri BC de A, Bargieri DY, Boscardin SB, Rodrigues MM, Ferreira LC de S. CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein [Internet]. Vaccine. 2010 ; 28( 5): 1373-1382.[citado 2024 maio 19 ] Available from: https://doi.org/10.1016/j.vaccine.2009.11.003
Vancouver
Braga CJM, Massis LM, Sbrogio-Almeida ME, Bargieri BC de A, Bargieri DY, Boscardin SB, Rodrigues MM, Ferreira LC de S. CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein [Internet]. Vaccine. 2010 ; 28( 5): 1373-1382.[citado 2024 maio 19 ] Available from: https://doi.org/10.1016/j.vaccine.2009.11.003
Trabalho de evento-resumo periodico
Analysis of immunogenicity of Plasmodium vivax merozoite surface protein 3 (MASP-3) in mice using different adjuvant formulations (2010)
Bittencourt, Amanda Romagnoli; Vicentin, Elaine Cristina; Braga, Catarina Joelma Magalhães; Ferreira, Luís Carlos de Souza ; Soares, Irene da Silva
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidades: ICB, FCF
Assuntos: PLASMODIUM, IMUNOGENÉTICA, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Amanda Romagnoli et al. Analysis of immunogenicity of Plasmodium vivax merozoite surface protein 3 (MASP-3) in mice using different adjuvant formulations. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 19 maio 2024. , 2010
APA
Bittencourt, A. R., Vicentin, E. C., Braga, C. J. M., Ferreira, L. C. de S., & Soares, I. da S. (2010). Analysis of immunogenicity of Plasmodium vivax merozoite surface protein 3 (MASP-3) in mice using different adjuvant formulations. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Bittencourt AR, Vicentin EC, Braga CJM, Ferreira LC de S, Soares I da S. Analysis of immunogenicity of Plasmodium vivax merozoite surface protein 3 (MASP-3) in mice using different adjuvant formulations. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 21 res. FCF038.[citado 2024 maio 19 ]
Vancouver
Bittencourt AR, Vicentin EC, Braga CJM, Ferreira LC de S, Soares I da S. Analysis of immunogenicity of Plasmodium vivax merozoite surface protein 3 (MASP-3) in mice using different adjuvant formulations. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 21 res. FCF038.[citado 2024 maio 19 ]
Artigo de periodico
Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium (2010)
Bargieri, Daniel Youssef ; Leite, Juliana A.; Lopes, Stefanie C. P.; Sbrogio-Almeida, Maria Elisabete; Braga, Catarina Joelma Magalhães; Ferreira, Luís Carlos de Souza ; Soares, Irene da Silva ; Costa, Fabio T. M.; Rodrigues, Mauricio M.
Fonte: Vaccine. Unidades: ICB, FCF
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARGIERI, Daniel Youssef et al. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium. Vaccine, v. 28, n. 16, p. 2818-2826, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2010.02.004. Acesso em: 19 maio 2024.
APA
Bargieri, D. Y., Leite, J. A., Lopes, S. C. P., Sbrogio-Almeida, M. E., Braga, C. J. M., Ferreira, L. C. de S., et al. (2010). Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium. Vaccine, 28( 16), 2818-2826. doi:10.1016/j.vaccine.2010.02.004
NLM
Bargieri DY, Leite JA, Lopes SCP, Sbrogio-Almeida ME, Braga CJM, Ferreira LC de S, Soares I da S, Costa FTM, Rodrigues MM. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium [Internet]. Vaccine. 2010 ; 28( 16): 2818-2826.[citado 2024 maio 19 ] Available from: https://doi.org/10.1016/j.vaccine.2010.02.004
Vancouver
Bargieri DY, Leite JA, Lopes SCP, Sbrogio-Almeida ME, Braga CJM, Ferreira LC de S, Soares I da S, Costa FTM, Rodrigues MM. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium [Internet]. Vaccine. 2010 ; 28( 16): 2818-2826.[citado 2024 maio 19 ] Available from: https://doi.org/10.1016/j.vaccine.2010.02.004

Unidades USP

ReP

Filtros

Autores

Assuntos

Título da fonte

Indexado em

Afiliação dos autores externos normalizada